Drugs / CAR-T
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07441291 | Nov 2025 → Dec 2027 expected | disease related to hematopoietic stem cell transplant | Peking University People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07441291 ↗ |
| Modality | Cell therapy | “CD19 chimeric antigen receptor T-cell (CAR-T) therapy” NCT07441291 ↗ |
| Target | CD19 | “CD19 CAR-T cells” NCT07441291 ↗ |